tag:blogger.com,1999:blog-30206473.post251139736191942679..comments2023-10-23T11:24:13.532-04:00Comments on Diabetes Update: Merck: We'll Continue to Profit from Killing CustomersJennyhttp://www.blogger.com/profile/17384082448952856117noreply@blogger.comBlogger1125tag:blogger.com,1999:blog-30206473.post-33732699000089712732007-05-15T14:51:00.000-04:002007-05-15T14:51:00.000-04:00This is scary stuff, indeed, and sounds very simil...This is scary stuff, indeed, and sounds very similar to what is happening with the anti-anemia drugs. The two big kidney dialysis companies, Fresenius and DaVita, and the drug company Amgen are putting patients at risk in order to boost their profits.<BR/><BR/>The New York Times had a story on May 9 about how Amgem is paying "hundreds of millions of dollars to doctors a year" to prescribe EpogenAnonymousnoreply@blogger.com